Emerging Markets Slowdown Trips Up Lilly’s 2014 Revenue Estimates
This article was originally published in PharmAsia News
Lilly says emerging markets represent “clear and significant opportunity” despite recent difficulties.
You may also be interested in...
Despite a slowdown, China’s pharma market passed Japan in 2013, two years faster than expected.